Clinical trial
Double-blinded Placebo-controlled Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women
NCT01742000 is registered in ClinicalTrials.gov with Institute for Atherosclerosis Research, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blinded Placebo-controlled Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women
- Lead sponsor
- Institute for Atherosclerosis Research, Russia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- October 31, 2012
- Enrollment
- 180 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.